Dr. Weissman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7867 N Kendall Dr
Suite 80
Miami, FL 33156Phone+1 305-595-0777Fax+1 305-412-9255- Is this information wrong?
Education & Training
- University of MichiganFellowship, Endocrinology, Diabetes, and Metabolism, 1970 - 1972
- University of Michigan Health SystemResidency, Internal Medicine, 1970 - 1972
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1967 - 1968
- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1966 - 1967
- New York University School of MedicineClass of 1966
Certifications & Licensure
- MI State Medical License Current
- FL State Medical License 1973 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:South Florida Castle Connolly, 2012
- SouthFloridaCEO: Top Doctors Castle Connolly, 2002-2003
- Join now to see all
Clinical Trials
- Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics Start of enrollment: 2011 Mar 01
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 16 citationsThree-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapyPhilip Home, Bo Ahrén, Jane E.B. Reusch, Marc Rendell, Peter N. Weissman
Diabetes Research and Clinical Practice. 2017-09-01 - 103 citationsHARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin wit...Peter N. Weissman, Molly C. Carr, June Ye, Deborah T. Cirkel, Murray Stewart
Diabetologia. 2014-09-11 - 59 citationsEffects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study.Peter N Weissman, Barry J. Goldstein, J Rosenstock, Brian Waterhouse, Alexander R. Cobitz
Current Medical Research and Opinion. 2005-11-04
Professional Memberships
- Fellow
Hospital Affiliations
- Baptist Hospital of MiamiMiami, Florida
- South Miami HospitalMiami, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: